{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:34:00Z","timestamp":1769240040718,"version":"3.49.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ijantimicag.2010.02.018","type":"journal-article","created":{"date-parts":[[2010,4,11]],"date-time":"2010-04-11T04:33:50Z","timestamp":1270960430000},"page":"94-95","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients"],"prefix":"10.1016","volume":"36","author":[{"given":"E. Paul","family":"O\u2019Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly K.","family":"Scarsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H.","family":"Scheetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Postelnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Cullina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.02.018_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.200109-012CC","article-title":"Aminoglycoside prescribing and surveillance in cystic fibrosis","volume":"167","author":"Tan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2010.02.018_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1008634911114","article-title":"Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis","volume":"20","author":"Touw","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ijantimicag.2010.02.018_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thx.51.4.369","article-title":"Minimisation of aminoglycoside toxicity in patients with cystic fibrosis","volume":"51","author":"Wood","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2010.02.018_bib4","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.018_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02961666","article-title":"Aminoglycoside induced ototoxicity in patients with cystic fibrosis","volume":"160","author":"Mulherin","year":"1991","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ijantimicag.2010.02.018_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00125817-200209000-00004","article-title":"Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?","volume":"4","author":"Tang","year":"2002","journal-title":"Genet Med"},{"key":"10.1016\/j.ijantimicag.2010.02.018_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0196-0709(97)90078-8","article-title":"Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity","volume":"18","author":"Fischel-Ghodsian","year":"1997","journal-title":"Am J Otolaryngol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791000110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791000110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T20:56:32Z","timestamp":1544561792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791000110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S092485791000110X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.02.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}